NCT03153124

Brief Summary

Patients with chronic kidney disease in hemodialysis have complex syndrome with diverse effects on cardiovascular, nervous, respiratory, musculoskeletal, immune and endocrine-metabolic systems. With regard to the musculoskeletal structure, there is progressive muscular loss with consequent increase in muscle weakness, limited resistance, exercise intolerance and fatigue, as well as functional and morphological abnormalities characteristic of uremic myopathy. Respiratory muscles are also affected as a result of uremic myopathy, with decreased strength and resistance. Objective: to analyze the impact of respiratory muscle training on muscle strength, functional capacity and quality of life of patients with chronic kidney disease on hemodialysis. Method: This is a prospective, randomized study involving 46 patients followed by the dialysis unit of a university hospital, over 18 years old, of both genders who underwent hemodialysis for more than six months and who signed the informed consent form. Patients will be allocated into two groups: respiratory muscle training with PowerBreath and control. All will be evaluated for demographic data, respiratory muscle strength, lung function, functional capacity and quality of life. The intervention group will perform three months of intradialytic training of a physical therapy protocol with PowerBreath. Both groups will be reevaluated after three months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 12, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 15, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2017

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2019

Completed
Last Updated

July 29, 2022

Status Verified

November 1, 2019

Enrollment Period

6 months

First QC Date

May 12, 2017

Last Update Submit

July 27, 2022

Conditions

Keywords

Respiratory muscle strengthRenal insufficiencyRespiratory muscle training

Outcome Measures

Primary Outcomes (5)

  • Manovacuometry

    RESPIRATORY MUSCLE FORCE

    Change from baseline in respiratory muscle force at 3 months

  • Spirometry

    Pulmonary Function

    Change from baseline in Pulmonary Function at 3 months

  • Distance in six-minute walk test

    analysis of distance

    change from baseline in distance at 3 months

  • Quality of life questionnaire

    Analysis of the quality of life

    change from baseline in quality of life at 3 months

  • HRR1

    heart rate recovery

    change from HR six minute walk test and seven minute

Study Arms (2)

Respiratory muscle training

EXPERIMENTAL

\- three months of intradialytic training of a physical therapy protocol with PowerBreath.

Other: Respiratory muscle training

Control

NO INTERVENTION

No intervention

Interventions

The intervention group will perform three months of intradialytic training of a physical therapy protocol with PowerBreath

Respiratory muscle training

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with chronic kidney disease undergoing hemodialysis for more than 6 months Both genders
  • ged 18 years or older
  • clinically stable
  • who agreed to participate in the study by signing a free informed consent form

You may not qualify if:

  • Patients with previous or current myoarticular or neurological disease;
  • That require some urgent or elective surgical intervention during the protocol;
  • Any cardiac decompensation such as arrhythmias, systolic blood pressure greater than 200mmHg or less than 60mmHg, diastolic blood pressure greater than 120mmHg or less than 40mmHg;
  • Decompensated diabetes mellitus and acute systemic infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Santa Casa of Sao Paulo Medical School

São Paulo, São Paulo, 01221-020, Brazil

Location

Related Publications (3)

  • Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.

    PMID: 23732715BACKGROUND
  • Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007 Aug;72(3):247-59. doi: 10.1038/sj.ki.5002343. Epub 2007 Jun 13.

    PMID: 17568785BACKGROUND
  • Kaltsatou A, Sakkas GK, Poulianiti KP, Koutedakis Y, Tepetes K, Christodoulidis G, Stefanidis I, Karatzaferi C. Uremic myopathy: is oxidative stress implicated in muscle dysfunction in uremia? Front Physiol. 2015 Mar 30;6:102. doi: 10.3389/fphys.2015.00102. eCollection 2015.

    PMID: 25870564BACKGROUND

MeSH Terms

Conditions

Renal Insufficiency, ChronicRenal Insufficiency

Interventions

Breathing Exercises

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHD

Study Record Dates

First Submitted

May 12, 2017

First Posted

May 15, 2017

Study Start

April 12, 2017

Primary Completion

September 30, 2017

Study Completion

April 30, 2019

Last Updated

July 29, 2022

Record last verified: 2019-11

Locations